Drug susceptibilities of yeast cells are affected by membrane lipid composition

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3695-3705

  Mukhopadhyay, Kasturi ^a   Kohli, Avmeet ^a   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ABC TRANSPORTER; ANTIFUNGAL AGENT; BENZYL ALCOHOL; CYCLOHEXIMIDE; ERGOSTEROL; FLUCONAZOLE; MEMBRANE LIPID; METHOTREXATE; PHENANTHROLINE; SPHINGOMYELIN; SULFOMETHURON METHYL; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; DRUG SENSITIVITY; FUNGUS GROWTH; FUNGUS MUTANT; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; YEAST CELL; BIOSYNTHESIS; DRUG EFFECT; GENETICS; MULTIDRUG RESISTANCE;

CANDIDA ALBICANS; DRUG RESISTANCE, MULTIPLE; ERGOSTEROL; MEMBRANE LIPIDS; SACCHAROMYCES CEREVISIAE;

EID: 0036894215     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3695-3705.2002     Document Type: Article

References (53)

1. Ansari, S., P. Gupta, S. K. Mahanty, and R. Prasad. 1993. The uptake of amino acids by erg mutants of Candida albicans. J. Med. Vet. Mycol. 31: 377-386.
2. Arthington-Skaggs, B. A., H. Jradi, T. Desai, and C. J. Morrison. 1999. Quantitation of ergosterol content: Novel method for determination of fluconazole susceptibility of Candida albicans. J. Clin. Microbiol. 37:3332-3337.
3. Arthington-Skaggs, B., W. Lee-Yang, M. A. Ciblak, J. P. Frade, M. E. Brandt, R. A. Hajjeh, L. H. Harrison, A. N. Sofair, and D. W. Warnock. 2002. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob. Agents Chemother. 46:2477-2481.
4. Bagnat, M., S. Keranen, A. Shevchenko, A. Shevchenko, and K. Simons. 2000. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc. Natl. Acad. Sci. USA 97:3254-3259.
5. Debry, P., E. A. Nash, D. W. Nekalson, and J. E. Metherall. 1997. Role of multidrug resistance P-glycoproteins in cholesterol esterification. J. Biol. Chem. 272:1026-1031.
6. Decottignies, A., A. M. Grant, J. W. Nichols, H. De Wet, D. B. McIntosh, and A. Goffeau. 1998. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273:12612-12622.
7. Dogra, S., S. Krishnamurthy, V. Gupta, B. L. Dixit, C. M. Gupta, D. Sanglard, and R. Prasad. 1999. Asymmetric distribution of phosphatidylethanolamine in C. albicans: Possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. Yeast 15:111-121.
8. Egner, R., F. E. Rosenthal, A. Kralli, D. Sanglard, and K. Kuchler. 1998. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Mol. Biol. Cell 9:523-543.
9. Emter, R., A. Hesse-Peck, and A. Kralli. 2002. ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms. FEBS Lett. 521:57-61.
10. Espinell-Ingroff, A., F. Barchiesi, K. C. Hazen, J. V. Martinez-Suarez, and G. Scalise. 1998. Standardization of antifungal susceptibility testing and clinical relevance. Med. Mycol. 36:68-78.
11. Ferte, J. 2000. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur. J. Biochem. 267:277-294.
12. Fling, M. E., J. Kopf, A. Tamarkin, J. A. Gorman, H. A. Smith, and Y. Koltin. 1991. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 227:318-329.
13. Gupta, V., A. K. Kohli, S. Krishnamurthy, N. Puri, S. A. Aalamgeer, S. L. Panwar, and R. Prasad. 1998. Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance and its in vitro transcriptional activation. Curr. Genet. 34:192-199.
14. Hallstrom, C. T., L. Lambert, S. Schorling, E. Balzi, A. Goffeau, and W. S. Moye-Rowley. 2001. Coordinate control of sphingolipid biosynthesis and multi-drug resistance in Saccharomyces cerevisiae. J. Biol. Chem. 26:23674-23680.
15. Hitchcock, C. A. 1993. Resistance of Candida albicans to azole antifungal agents. Biochem. Soc. Trans. 21:1039-1047.
16. Hitchcock, C. A., K. Barrett-Bee, and N. J. Russel. 1986. The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J. Gen. Microbiol. 132:2421-2431.
17. Hitchcock, C. A., N. J. Russel, and K. J. Barrett-Bee. 1987. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans. CRC Crit. Rev. Microbiol. 15:111-115.
18. Jensen-Pergakes, K. L., M. A. Kennedy, N. D. Lees, R. Barbuch, C. Koegel, and M. Bard. 1998. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: Drug susceptibility studies in erg6 mutants. Antimicrob. Agents Chemother. 42:1160-1167.
19. Kaur, R., and A. K. Bachhawat. 1999. The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae. Microbiology 145:809-818.
20. Kean, L. S., A. M. Grant, C. Angeletti, Y. Mahe, K. Kuchler, R. S. Fuller, and J. W. Nichols. 1997. Plasma membrane translocation of fluorescent-labeled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3. J. Cell Biol. 138:255-270.
21. Kelly, S. L., D. C. Lamb, D. E. Kelly, J. Loffler, and H. Einsele. 1996. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients. Lancet 348:1523-1524.
22. 5,6-desaturation. FEBS Lett. 400:80-82.
23. Kohli, A., Smriti, K. Mukhopadhyay, A. Rattan, and R. Prasad. 2002. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob. Agents Chemother. 46:1046-1052.
24. Kohli, A., V. Gupta, S. Krishnamurthy, S. E. Hasnain, and R. Prasad. 2001. Specificity of drug transport mediated by CaMDR1: A major facilitator of Candida albicans. J. Biosci. 26:333-339.
25. Kontoyiannis, D. P. 2000. Efflux mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae. J. Antimicrob. Chemother. 46:199-203.
26. Kontoylannis, D. P. 2000. Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cerevisiae. J. Antimicrob. Chemother. 46:191-197.
27. 22-desaturase from the pathogenic fungus Candida glabrata. Antimicrob. Agents Chemother. 43:1725-1728.
28. Lees, N. D., B. Skaggs, D. R. Kirsch, and M. Bard. 1995. Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae - A review. Lipids 30:221-226.
29. Leppert, G., R. McDevitt, S. C. Falco, F. I. M. Van Dyk, and J. Golin. 1990. Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces. Genetics 125:13-20.
30. Loffler, J., H. Einsele, H. Hebart, U. Schumacher, C. Hrastnik, and G. Daum. 2000. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol. Lett. 185:59-63.
31. Lopez-Ribot, J. L., R. K. McAtee, S. Perea, W. R. Kirkpatrick, M. G. Rinaldi, and T. F. Patterson. 1999. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 43:1621-1630.
32. Luker, G. D., C. M. Pica, A. S. Kumar, D. F. Covey, and D. Piwnica-Worms. 2000. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. Biochemistry 39:7051-7661.
33. Marichel, P., H. Vanden Bossche, F. C. Odds, G. Nobels, D. W. Warnock, V. Timmerman, C. Van Broeckhoven, S. Fay, and P. Mose-Larsen. 1997. Molecular-biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 41:2229-2237.
34. Metherall, J. E., H. Li, and K. Waugh. 1996. Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis. J. Biol. Chem. 271:2634-2640.
35. Miyazaki, Y., A. Geber, H. Miyazaki, D. Falconer, T. Parkinson, C. Hitchcock, B. Grimberg, K. Nyswaner, and J. E. Bennett. 1999. Cloning, sequencing, expression and allelic sequence diversity of ERG3 (c-5 sterol desaturase gene) in Candida albicans. Gene 236:43-51.
36. Nakamura, K., M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottignies, B. C. Monk, A. Goffeau, and R. D. Cannon. 2001. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45:3366-3374.
37. Nolte, F. S., T. Parkinson, D. J. Falconer, S. Dix, J. Williams, C. Gilmore, R. Geller, and J. R. Wingard. 1997. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob. Agents Chemother. 41:196-199.
38. Panwar, S. L., S. Krishnamurthy, V. Gupta, A.-M. Alarco, M. Raymond, D. Sanglard, and R. Prasad. 2001. CaALK8, an alkane assimilating cytochrome P450 confers multidrug resistance when expressed in a hypersensitive strain of Candida albicans. Yeast 18:1117-1129.
39. Perepnikhatka, V., F. J. Fischer, M. Niimi, R. A. Baker, R. D. Cannon, Y.-K. Wang, F. Sherman, and E. Rustchenko. 1999. Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans. J. Bacteriol. 181:4041-4049.
40. Pesti, M., J. M. Campbell, and J. F. Peberdy. 1981. Alteration of ergosterol content and chitin synthase activity in Candida albicans. Curr. Microbiol. 5:187-190.
41. Prasad, R., S. L. Panwar, and S. Krishnamurthy. 2002. Drug resistance mechanisms of human pathogenic fungi, p. 601-631. In R. A. Calderone and R. L. Cihlar (ed.), Fungal Pathogenesis: Principles and Clinical Applications. Marcel Dekker, Inc., New York, N.Y.
42. Prasad, R., S. L. Panwar, and Smriti. 2002. Drug resistance in yeasts - An emerging scenario. Adv. Microb. Physiol. 46:155-201.
43. Prasad, R., P. D. Worgifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterisation of a novel gene of C. albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
44. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to anti-fungal agents: Molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
45. Sharom, F. J. 1996. The P-glycoprotein multidrug transporter: Interactions with membrane lipids, and their modulation of activity. Biochem. Soc. Trans. 25:1088-1096.
46. Sinicrope, F. A., P. K. Dudeja, B. M. Bissonnette, A. R. Safa, and T. A. Brasitus. 1992. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J. Biol. Chem. 267:24995-25002.
47. Smriti, S. Krishnamurthy, and R. Prasad. 1999. Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans. FEMS Microbiol. Lett. 173:475-481.
48. Smriti, S. Krishnamurthy, V. Puri, B. L. Dixit, C. M. Gupta, and R. Prasad. 2002. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators, Yeast 19:1-16.
49. Swain, E., K. Baudry, J. Stukey, V. McDonough, M. Germann, and J. T. Nickels, Jr. 2002. Sterol-dependent regulation of sphingolipid metabolism in Saccharomyces cerevisiae. J. Biol. Chem. 277:26177-26184.
50. Talibi, D., and M. Raymond. 1999. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae. J. Bacteriol. 181:231-240.
51. Van Den Hazel, H. B., H. Pichler, M. A. Do Valle Matta, E. Leitner, A. Goffeau, and G. Daum. 1999. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs. J. Biol. Chem. 274:1934-1941.
52. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
53. Zweytick, D., C. Hrastnik, S. D. Kohlwein, and G. Daum. 2000. Biochemical characterization and subcellular localization of the sterol C-24(28) reductase, Erg4p, from the yeast Saccharomyces cerevisiae. FEBS Lett. 470:83-87.